# OnCo record bain-capital-life-sciences (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/bain-capital-life-sciences/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "bain-capital-life-sciences" ;
  schema:name "Bain Capital Life Sciences"@en ;
  schema:description "The life sciences investing arm of Bain Capital in Boston. It funds later-stage private and public biotech companies, including cancer drug developers such as Olema Oncology, Nuvalent, Revolution Medicines and Mersana."@en ;
  schema:url <https://onco.cc/companies/bain-capital-life-sciences/>, <https://www.baincapitallifesciences.com/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://www.baincapitallifesciences.com/>, <https://www.baincapitallifesciences.com/portfolio>, <https://www.baincapitallifesciences.com/about> ;
  onco:tag "vc" ;
  schema:addressCountry "US" ;
  onco:companies <https://onco.cc/companies/mersana/>, <https://onco.cc/companies/nurix/>, <https://onco.cc/companies/nuvalent/>, <https://onco.cc/companies/replimune/>, <https://onco.cc/companies/revolution-medicines/> .
